AUS
NZ
UK
CA
USA
IND
Healt
ASX 200 Healthcare Stocks: Is Value Emerging After Sell-Off?
April 10, 2026 11:06 AM AEST| By SamASX healthcare stocks face pressure, but emerging value opportunities and companies like Telix highlight long-term growth potential within the ASX 200 sector.
ASX Biotech Stock CHM Crashes: Panic or Opportunity?
April 10, 2026 10:39 AM AEST| By SamChimeric Therapeutics faces sharp decline amid heavy selling, highlighting volatility in ASX biotech small-cap stocks and broader sector pressure.
ASX Healthcare Stock CGS Adds Shares in Quiet Move
April 10, 2026 10:09 AM AEST| By SamCogstate lists additional shares on the ASX following securities conversion, reflecting routine capital management within the healthcare technology sector.
ASX Healthcare Stock Jumps on Breakthrough Momentum
April 10, 2026 09:56 AM AEST| By SamEBR Systems gains traction as its wireless cardiac technology expands clinical use, strengthens hospital networks, and advances commercial rollout in Australia’s healthcare sector.
ASX Healthcare Stocks Rebound Story: Hidden Value Emerging
April 10, 2026 09:49 AM AEST| By SamASX healthcare stocks have faced recent pressure, but companies like Telix, Mayne Pharma and EBR Systems are drawing attention as innovation and commercial progress continue to shape sector dynamics.
ASX All Ordinaries Healthcare Update as EBR Restructures
April 10, 2026 09:45 AM AEST| By SamEBR Systems completes reverse stock split and prepares for trading resumption, reflecting corporate restructuring within the ASX All Ordinaries healthcare sector.
Is Mesoblast’s Latest FDA Nod a Turning Point or a Pause?
April 09, 2026 08:15 PM AEST| By SamMesoblast gains attention after FDA clearance for Ryoncil trial, sparking debate around valuation, pipeline strength, and future growth in the biotech sector.
All Ordinaries: SHG (ASX:SHG) Shares Update on Capital Move
April 09, 2026 07:20 PM AEST| By SamSingular Health expands share capital through new quotation, reflecting capital management activity within the technology and healthcare sector across the All Ordinaries index.
ASX Biotech Update: AI Radiation Planning and Healthcare Innovation
April 09, 2026 05:04 PM AEST| By SamBiotech sector developments highlight AI-driven radiation planning collaboration, showcasing integration of advanced technology with clinical expertise in healthcare systems.
Can Paradigm Biopharma (ASX:PAR) Reach Profit Soon?
April 09, 2026 03:44 PM AEST| By SamParadigm Biopharmaceuticals’ journey toward profitability highlights growth ambitions, financial challenges, and evolving biotech trends shaping its future direction.
Why Mesoblast (ASX:MSB) Is Gaining Attention in ASX 200 Healthcare Stocks
April 09, 2026 03:41 PM AEST| By SamMesoblast activity highlighted developments within the ASX healthcare sector, reflecting biotechnology innovation and evolving market participation across global medical industries.
Is RACura Oncology Limited (ASX:RAC) Building Strength in All Ordinaries Biotech Sector?
April 09, 2026 03:03 PM AEST| By SamRACura Oncology progresses share quotation, highlighting developments within the healthcare and biotechnology sector across the All Ordinaries index.
Is This Wireless Pacing Breakthrough Changing Heart Care?
April 09, 2026 02:58 PM AEST| By SamEBR Systems highlights strong progress in wireless cardiac pacing, driven by rising adoption, expanding physician training, and ongoing clinical advancements in heart failure treatment.
Telix Moves Quietly—But Could This Subtle ASX Update Matter More Than It Seems?
April 09, 2026 11:04 AM AEST| By SamTelix adds new shares to ASX listing, reflecting steady capital strategy within the healthcare sector.
ASX 200 Tech Star Under Pressure: Is Pro Medicus Losing Its Shine?
April 09, 2026 10:30 AM AEST| By SamPro Medicus faces valuation scrutiny despite strong growth, reflecting shifting sentiment within the ASX 200 healthcare technology sector.
ASX All Ordinaries Healthcare Stock: Cogstate Surge Sparks Fresh Debate
April 09, 2026 10:10 AM AEST| By SamCogstate shares surge on strong contract growth and healthcare demand, highlighting its role in the All Ordinaries healthcare technology sector.
AI Healthcare Buzz: Artrya Shares Surge on Imaging Momentum
April 09, 2026 10:02 AM AEST| By SamArtrya gains attention as AI-driven healthcare imaging demand rises, highlighting growth opportunities within the All Ordinaries and evolving medical technology sector.
Mesoblast (ASX:MSB) ASX 200 Biotech Sector Activity Explained?
April 09, 2026 03:12 AM AEST| By SamMesoblast reflects ASX 200 and ASX 300 biotechnology sector activity, highlighting clinical development processes and healthcare innovation participation.
All Ordinaries: Paradigm Biopharma Files to List 6M Shares
April 08, 2026 08:09 PM AEST| By SamParadigm Biopharmaceuticals (ASX:PAR) applies for new shares on all ordinaries, adjusting the capital structure through options conversions while remaining compliant with ASX listing rules.
ASX Update: Artrya All Ordinaries Share Activity
April 08, 2026 05:53 PM AEST| By SamArtrya reflects ASX 300 and All Ordinaries healthcare technology sector activity through share quotation, highlighting capital structure processes and medical innovation.
Advertise your brand on Kalkine Media